Serina Therapeutics Inc is a biotech company making strides in regenerative biology and aging treatments, with a focus on innovation and potential to revolutionize the health care sector.

Serina Therapeutics Inc. reports Q1 2025 financial results, including $15 million in equity financing, board expansion, and advancements in its POZ-lipid technology.